- In January 2024, BrainQ Technologies announced positive results from their Phase 2a trial of a non-invasive brain stimulation therapy for visual agnosia. This technology has the potential to offer significant advantages over current treatments involving medication or surgery due to its non-invasive nature
- In December 22, 2023, researchers at the University of California, San Francisco discovered a new genetic mutation associated with a specific type of agnosia. This breakthrough has the potential to pave the way for targeted therapy development, leading to more personalized treatment approaches in the future
- In November 17, 2023, several academic institutions started conducting research on using virtual reality (VR) for agnosia rehabilitation. VR environments can provide controlled stimuli and personalized training programs, which have the potential to improve sensory recognition and cognitive function
- In January 23, 2024, the National Institute of Neurological Disorders and Stroke (NINDS) announced that it continues to fund research on agnosia and related disorders. This funding provides valuable resources for further development and advancement in the field
- In January 23, 2024, patient advocacy groups such as the American Academy of Neurology and the National Organization for Rare Disorders (NORD) announced their efforts to raise awareness about agnosia and advocate for increased research funding. Their initiatives aim to support patients and promote advancements in treatment
